2027 Future Talent Program - Oral Formulation Sciences - Co-op

Future Talent Program Scientist The Future Talent Program features Cooperative (Co-op) education that lasts up to 6 months and will include one or more projects. These opportunities in our Research Labs Division can provide you with great development and a chance to see if we are the right company for your long-term goals. Our company's Pharmaceutical Sciences organization translates molecules to medicines, working from the discovery interface through registration stability manufacturing by designing, developing and scaling-up the formulation, device, and manufacturing process. Driving drug product design from the bench top to the Good Manufacturing Practice (GMP) manufacturing facilities, our Scientists use cutting edge science to transform drug delivery and manufacturing technology to positively impact patients. The successful candidate will be a passionate Scientist with strong academic fundamentals and a drive to develop new medicines to improve human health. In this role, the individual will be responsible for exploring new formulation, drug delivery, and manufacturing process science for oral solid dosage products as part of a co-op experience starting in Summer 2027 and continuing through the fall semester. Additional responsibilities are as follows: Develops and applies basic principles and scientific concepts to execute work in a laboratory or pilot plant environment to advance new solid oral drug products. Capability to support manufacturing operations in pilot plant environments. Executes routine experiments and data interpretation with appropriate technical guidance. Ability to operate and trouble shoot equipment and processes. Capable of learning practical laboratory/pilot plant skills and fundamental scientific principles to utilize as part of their daily responsibilities. Works well with others in collaborative team environments. Education Minimum Requirement: Actively pursuing a B.S. or M.S. degree or Ph.D. degree in Chemical Engineering, Biomedical Engineering, Pharmaceutical Sciences or related discipline (expected no later than June 2028).